Skip to content
Back
Most recent
Foundation campaigns for equity
The Foundation continues its campaign against unfairness in the National Disability Insurance Scheme.
Eylea and Lucentis switching
The Foundation welcomes the decision to allow switching of age-related macular degeneration drugs Eylea and Lucentis.
Awareness campaign kicks off
A powerful ‘How’s your macula?’ television advertisement has been produced by the Macular Degeneration Foundation.
AMD treatment switching campaign
There has been a big community response to the Foundation’s campaign to allow AMD drug “switching”.
mEYE World 2012
Macular Degeneration Foundation has announced, as part of World Sight Day activities, the winners of the mEYE World Photographic Competition 2012.
TV campaign
The Macular Degeneration Foundation has launched a new national awareness campaign that featured symptom recognition.
Global leaders discuss wet AMD
International experts met in Sydney in 2012 to develop a road map for the management of wet age-related macular degeneration.
Switching should be allowed
With a new treatment for wet AMD coming on the market, drug switching between Lucentis and Eylea should be allowed.
Focus on families
Research has revealed Australians significantly underestimate the role of family history in developing macular degeneration.